Narcan maker expects approval for OTC anti-opioid spray

FDA to give priority review to nonprescription form of naloxone, a life-saving drug used to treat suspected drug overdoses.

Narcan maker expects approval for OTC anti-opioid spray
FDA to give priority review to nonprescription form of naloxone, a life-saving drug used to treat suspected drug overdoses.